CLINICAL_TRIALS
trial_result
· 2011-06-13
Clinical Trial Update: Three-Arm Study of the Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis [Phase 3]
Summary
A Phase 3 trial evaluating the safety and efficacy of pirfenidone in idiopathic pulmonary fibrosis has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Genentech, Inc. | Conditions: Idiopathic Pulmonary Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2011-06-13